Knowledge Content Library

Portfolio & Decision Analysis and the Fight Against Antimicrobial Resistance

Jon Mauer, Pfizer
June 17, 2015 (SDP Webinar - Invited Talk)

Many solutions had been proposed by stakeholders from professional groups, academia and government to reinvigorate antibiotic drug development and address the emerging threat of infection posed by drug-resistant pathogens. This presentation illustrates how decision analysis clarified what solutions would address the problems most effectively and aligned stakeholders to rally support for specific changes in public policy that would have the most impact towards stimulating antibiotic development. President Obama signed the Generating Antibiotic Incentives Now Act (i.e., GAIN Act) into law to help create a robust and sustainable antibacterial research and development infrastructure and early signs show it is having the desired effect.

Click on the file below to hear a sample of the presentation.  

Click here for access to the full video and pdf.

SDP membership is required for full access to this and all other archived webinars.

Keywords: project framing framestruc, evaluation anamod, portfolio decision analysis portda, stakeholders

   Email | Print